       Document 1924
 DOCN  M94A1924
 TI    Attitude of HIV(+) workers facing personnel reduction in a large firm of
       Kinshasa.
 DT    9412
 AU    Khondi N; Mposo N; Nzila N; Doppagne A; Kilombo N; Projet Sida, Antwerp,
       Belgium.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):420 (abstract no. PD0289). Unique
       Identifier : AIDSLINE ICA10/94370651
 AB    OBJECTIVE: To evaluate the attitude of HIV(+) Workers facing Personnel
       reduction as economical rehabilitation measure in a large business of
       Kinshasa, in a crisis period. METHODS: To probe 1,383 employee records
       in the largest commercial bank of Kinshasa, where a general screening
       was performed yearly, with HIV test and seronotification, from 1988 to
       1991. To count the dismissions operated in the bank consecutively to
       grave disturbances (Lootings). To determine the HIV(+) rate among the
       laid-off employees, their attitude facing that issue, in comparison of
       HIV seroprevalence and seroincidence among all the workers. RESULTS: a)
       Relative stabilization of the HIV infection: seroprevalence = 5.8%,
       seroincidence < 1% (0.6%), b) Important Personnel reduction since
       october 1993: 1,320 to 1,070 workers = 250 (-19%) c) Vehement
       protestation and menaces of Law actions by all the laid-off HIV(+)
       workers, d) Number of HIV(+) workers dismissed: 16/250 = 6.4%. Compared
       to HIV seroprevalence and seroincidence: 5.8% x 250 = 14.5 (15), e)
       Annual average indexes between HIV(+) and HIV(-) workers in the bank
       clinic: Consultation days: 23/18. Sickness non attendance: 3/0.4
       Hospitalization days: 1/0.2. Expenses tied to Treatment (USD): 419/254.
       DISCUSSION AND CONCLUSION: HIV(+) workers consider Personnel reduction
       as a discrimination for them. Truly the medical secret has never been
       divulgated to the Employer: a lot of other objective elements are
       considered and lead at that issue.
 DE    Contact Tracing  *Employment  Human  *HIV Seropositivity  *HIV
       Seroprevalence  *Prejudice  Zaire  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

